Market Research Logo

Sweden Pharmaceuticals & Healthcare Q1 2019

Sweden Pharmaceuticals & Healthcare Q1 2019

Key View:

Sudan's currency devaluation has led to the shortage of a number of medicines, with some products also becomingcompletely unavailable for sale in the country. The need to import active pharmaceutical ingredients (APIs) will mean the marketremains extremely vulnerable to currency fluctuations and external headwinds. Donations are likely to play an important role in theshort to medium term, as the elevated industry and operational risks continue to undermine any major pharmaceutical companyactivity.


Key View
SWOT
Industry Forecast
Pharmaceutical Market
Healthcare Market
Prescription Drug Market
Patented Drug Market
Generic Drug Market
OTC Medicine Market
Pharmaceutical Trade
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Sweden Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
AstraZeneca
Meda
Medivir
Novartis
Swedish Orphan Biovitrum (SOBI)
Sweden Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report